About 80 per cent respondents in India willing to get COVID-19 vaccine: RDIF survey

18-Nov-2020

A survey conducted by the Russian Direct Investment Fund (RDIF), Russia�s sovereign wealth fund, has found that about 80 per cent of people surveyed in India would like to be vaccinated against COVID-19, the disease caused by the novel coronavirus or SARS-CoV-2. The results of the survey of 12,000 respondents in 11 countries regarding coronavirus vaccination and preferences in vaccine selection were published by the RDIF on Tuesday. According to the survey results, 73 per cent of the respondents were willing to be vaccinated against coronavirus infection, while of those aware of Russia�s Sputnik V vaccine and willing to be vaccinated the number was even higher - 4 out of every 5 respondents. It said an increase in the proportion of those aware of the Russian vaccine and willing to be vaccinated, shows, among other things, the high level of confidence in Russia as a global vaccine manufacturer. The RDIF release also said the human adenoviral vector platform, on which the Sputnik V vaccine is based, is almost nine times more reliable than the non-human adenovirus platform. �In India, there is high confidence in the human adenovirus vaccine (Sputnik V platform) as 9 out of 10 vaccine respondents preferred this platform over non-human adenovirus platforms. Russia ranks first among foreign vaccine-manufacturing countries (excluding India), which were mentioned by respondents primarily as the most trustworthy. Overall, 5 out of 10 respondents said that Russia is one of the most reliable countries (each respondent mentioned three countries),� said the survey. As per the survey, 60 per cent of the respondents are aware of the Russian Sputnik V vaccine - the highest awareness level among the countries that participated in the survey, on par with respondents from Mexico. Among those who are aware of the Russian Sputnik V vaccine, the percentage of those who are willing to be vaccinated is even higher - over 85 per cent of those surveyed. The survey was conducted from October 9-19 by YouGov, a leading UK research data and analytics group. The survey included people from Brazil, Vietnam, Egypt, India, Indonesia, Malaysia, Mexico, Nigeria, UAE, Saudi Arabia and the Philippines. More than 2.5 billion people live in these countries, or over 30 per cent of the world�s population. The survey was conducted prior to the announcement that the Sputnik V vaccine is 92 per cent effective at protecting people from COVID-19 based on interim trial results from phase 3 trials involving 40,000 volunteers.